ExPLoRNA Therapeutics receives funding to advance its novel mRNA technology
Funding from the Bill & Melinda Gates Foundation will go toward understanding the benefits of novel cap analogs for therapeutic applications WARSAW, Poland, Dec. 8, 2022 /PRNewswire/ — ExPLoRNA Therapeutics, a Polish biotech company revolutionizing